CoChat

p53 modifications: exquisite decorations of the powerful guardian

Open access
Liu, Yanqing, Tavana, Omid, Gu, Wei · 2019 · Journal of Molecular Cell Biology

The DOI matches its Crossref record; 207 of the 209 references it cites were found in a registry or an index.

Abstract

The last 40 years have witnessed how p53 rose from a viral binding protein to a central factor in both stress responses and tumor suppression. The exquisite regulation of p53 functions is of vital importance for cell fate decisions. Among the multiple layers of mechanisms controlling p53 function, posttranslational modifications (PTMs) represent an efficient and precise way. Major p53 PTMs include phosphorylation, ubiquitination, acetylation, and methylation. Meanwhile, other PTMs like sumoylation, neddylation, O-GlcNAcylation, adenosine diphosphate (ADP)-ribosylation, hydroxylation, and β-hydroxybutyrylation are also shown to play various roles in p53 regulation. By independent action or interaction, PTMs affect p53 stability, conformation, localization, and binding partners. Deregulation of the PTM-related pathway is among the major causes of p53-associated developmental disorders or diseases, especially in cancers. This review focuses on the roles of different p53 modification types and shows how these modifications are orchestrated to produce various outcomes by modulating p53 activities or targeted to treat different diseases caused by p53 dysregulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jmcb/mjz060

Cites

207 of 207 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Overview of p53 PTMs. The major sites for p53 modifications (phosphorylation, ubiquitination, sumoylation, neddylation, acetylation, methylation, O-GlcNAcylation, ADP-ribosylation, hydroxylation, and β-hydroxybutyrylation) are plotted. Different colors are used to differentiate distinct modification types. Representative functions of some modifications are indicated. The figure is mainly revised from Dai and Gu (2010) and Gu and Zhu (2012) and not drawn to scale.
Figure 1 Overview of p53 PTMs. The major sites for p53 modifications (phosphorylation, ubiquitination, sumoylation, neddylation, acetylation, methylation, O-GlcNAcylation, ADP-ribosylation, hydroxylation, and β-hydroxybutyrylation) are plotted. Different colors are used to differentiate distinct modification types. Representative functions of some modifications are indicated. The figure is mainly revised from Dai and Gu (2010) and Gu and Zhu (2012) and not drawn to scale.CC BY-NC · PubMed Central
Figure 2 PTMs can regulate p53 in different modes. (A) Phosphorylation at S33, T81, and S315 of p53 provides docking motif for Pin1. (B) Phosphorylations at p53 N-terminal mask it with negative electrostatic forces to facilitate the binding of CBP/p300 with positive electrostatic forces. (C and D) Mdm2 polyubiquitinates p53 for proteasomal degradation whereas monoubiquitinates it for nuclear export. (E) Acetylation at K120 by Tip60 may cause p53 conformational change, making it bind to specific target gene promoter. (F) Certain p53 modifications may help establish phase separation with other regulators.
Figure 2 PTMs can regulate p53 in different modes. (A) Phosphorylation at S33, T81, and S315 of p53 provides docking motif for Pin1. (B) Phosphorylations at p53 N-terminal mask it with negative electrostatic forces to facilitate the binding of CBP/p300 with positive electrostatic forces. (C and D) Mdm2 polyubiquitinates p53 for proteasomal degradation whereas monoubiquitinates it for nuclear export. (E) Acetylation at K120 by Tip60 may cause p53 conformational change, making it bind to specific target gene promoter. (F) Certain p53 modifications may help establish phase separation with other regulators.CC BY-NC · PubMed Central
Figure 3 Crosstalk between p53 modifications. There are widespread interplays between p53 modifications. These crosstalks can be divided into different types via diverse standards. For example, homogeneous modification crosstalk (phosphorylation of S15 boosts the latter phosphorylation at T18) vs. heterogeneous modification crosstalk (ubiquitination and acetylation compete for K320 and six C-terminal lysine residues), nearby modification crosstalk (methylation of K372 can promote acetylation of local K373 and K382) vs. distant modification crosstalk (phosphorylation at N-terminus influences the acetylation at C-terminus), or cooperative modification crosstalk (the case that K372 methylation promotes K373 and K382 acetylation can also be categorized as cooperative modification crosstalk) vs. antagonistic modification crosstalk (T377 and S378 phosphorylation inhibits K373 and K382 acetylation). For detailed discussion, see the context. Black arrows indicate positive effects. Red perpendicular bars indicate negative effects.
Figure 3 Crosstalk between p53 modifications. There are widespread interplays between p53 modifications. These crosstalks can be divided into different types via diverse standards. For example, homogeneous modification crosstalk (phosphorylation of S15 boosts the latter phosphorylation at T18) vs. heterogeneous modification crosstalk (ubiquitination and acetylation compete for K320 and six C-terminal lysine residues), nearby modification crosstalk (methylation of K372 can promote acetylation of local K373 and K382) vs. distant modification crosstalk (phosphorylation at N-terminus influences the acetylation at C-terminus), or cooperative modification crosstalk (the case that K372 methylation promotes K373 and K382 acetylation can also be categorized as cooperative modification crosstalk) vs. antagonistic modification crosstalk (T377 and S378 phosphorylation inhibits K373 and K382 acetylation). For detailed discussion, see the context. Black arrows indicate positive effects. Red perpendicular bars indicate negative effects.CC BY-NC · PubMed Central
Figure 4 Targeting wild-type p53 modification for disease therapy. Various small-molecular compounds have been developed to target the major enzymes in wild-type p53 modification pathways. These targets and molecules include Mdm2 (Nutlins, TDP665759, and MI-319), Mdmx (SJ172550), Mdm2 and Mdmx (ATSP-7041), HAUSP (P22077, P5049, and HBX41108), and Sirt1 (tenovins). Black arrows indicate positive effects. Red perpendicular bars indicate negative effects.
Figure 4 Targeting wild-type p53 modification for disease therapy. Various small-molecular compounds have been developed to target the major enzymes in wild-type p53 modification pathways. These targets and molecules include Mdm2 (Nutlins, TDP665759, and MI-319), Mdmx (SJ172550), Mdm2 and Mdmx (ATSP-7041), HAUSP (P22077, P5049, and HBX41108), and Sirt1 (tenovins). Black arrows indicate positive effects. Red perpendicular bars indicate negative effects.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 207 references

Cited by

See all 393

Metadata

Authors
Liu, Y., Tavana, O., & Gu, W.
Affiliations
  • Columbia University (US)
  • Herbert Irving Comprehensive Cancer Center (US)
Corresponding author
Gu, Wei
Venue
Journal of Molecular Cell Biology
Published
2019-07
Volume
11
Issue
7
Pages
564-577
ISSN
  • 1674-2788 (ISSN-L)
  • 1759-4685
OpenAlex
W2961184804
Cited by
392
References
209
Citations by year
2026: 31 · 2025: 47 · 2024: 49 · 2023: 73 · 2022: 83 · 2021: 63 · 2020: 40 · 2019: 5
FWCI
4.55
Type
journal article
Language
en
Open access
Locations
  • Journal of Molecular Cell Biology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
National Cancer Institute of the National Institutes of Health (5R01CA193890, 5R01CA085533, 5R01CA190477, 5R01CA216884)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
p53, post-translational modification, phosphorylation, ubiquitination, acetylation, methylation, SUMOylation, neddylation, O-GlcNAcylation, ADP-ribosylation, hydroxylation, β-hydroxybutyrylation, p53 stabilization, tumor suppression, stress response, cancer, developmental disorders
MeSH terms
Animals, Humans, Neoplasms, Protein Processing, Post-Translational, Tumor Suppressor Protein p53, History, 20th Century, History, 21st Century, Protein Stability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: p53 modifications: exquisite decorations of the powerful guardian. https://app.cochat.ai/papers/10.1093/jmcb/mjz060
The paper
Liu, Y., Tavana, O., & Gu, W. (2019). p53 modifications: exquisite decorations of the powerful guardian. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjz060

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.